Informed Consent: A Monthly Review
_________________

July 2023 :: Issue 55

This digest aggregates and distills key content addressing informed consent from a broad spectrum of peer-reviewed journals and grey literature, and from various practice domains and organization types including international agencies, INGOs, governments, academic and research institutions, consortiums and collaborations, foundations, and commercial organizations. We acknowledge that this scope yields an indicative and not an exhaustive digest product.

Informed Consent: A Monthly Review is a service of the Center for Informed Consent Integrity, a program of the GE2P2 Global Foundation. The Foundation is solely responsible for its content. Comments and suggestions should be directed to:

Editor
Paige Fitzsimmons, MA
Associate Director, Center for Informed Consent Integrity
GE2P2 Global Foundation
paige.fitzsimmons@ge2p2global.org

PDF Version: Center for Informed Consent Integrity – A Monthly Review_July 2023

Spotlight Articles

This month our spotlight section focuses on strategies to strengthen informed consent for persons with disabilities. The first article is by Boie et al., publishing in Investigative Ophthalmology & Visual Science –  Adaptations to the administration of informed consent when conducting research with older adults that are deafblind. The authors investigate ways that new technologies can be used to overcome barriers faced by people living with “deafblindness”. They propose easy-to-implement adaptations of IC content to alternative and adapted formats for the administration of informed consent/assent helping protect patient autonomy and dignity, as well as confidentiality.

ASL Consent in the Digital Informed Consent Process by Kosa et al., appears in the Journal on Technology & Persons with Disabilities.  In this article, the authors propose to use machine learning technologies in an app which enables consent transactions via American Sign Language. This innovation – which they coin as “ASL consent” – helps to overcome existing text/spoken language barriers to help reach patient populations who may be otherwise excluded from research.

Adaptations to the administration of informed consent when conducting research with older adults that are deafblind
Norman Robert Boie, Atul Jaiswal, Walter Wittich
Investigative Ophthalmology & Visual Science, June 2023
Abstract
Purpose
Multiple access barriers exist for persons with deafblindness that want to participate in research. The process of informed written consent is not easily accessible for persons with deafblindness, and its administration is often regulated by institutional review boards that have little or no experience accommodating this process. The purpose of this study was to explore alternative and adapted formats for the administration of informed consent/assent in research with older adults living with reduced or absent functional vision and hearing.
Methods
Within the context of a larger project on deafblindness and health service access during the COVID-19 pandemic, we recruited 32 persons (Age 59 to 91, M = 77) with deafblindness, through rehabilitation centres in Canada. The research assistant systematically tracked communication formats and accessibility requirements and coordinated with the rehabilitation centres to adjust the consent process according to the requirements and preferences of each participant. He took systematic field notes and compiled all adaptations, which were later analyzed using qualitative description.
Results
We converted our approved consent text into free-format electronic versions or paper-format without logos, line boxes, or bullet points, to facilitate easy access through scanners or screen readers. For participants who communicated through interpreters, we adapted the process to make interpretation into sign language easier. Verbal consent could be recorded for individuals where paper signatures posed a barrier. For the administration of demographic questionnaires, we eliminated check boxes and accepted verbal or signed response formats that could be more easily recorded. The main outcome of these adaptations was to allow our research participants with deafblindness to access and complete their informed consent process as independently as possible. Not only did these adaptations protect confidentiality and dignity, but their implementation facilitated the subsequent qualitative interviews in the most autonomous way possible.
Conclusions
These adaptations contributed to the experience of our participants and increased the capacity of our team by developing skills centered around flexibility, patience, respect and trust. This improved communication and empathy, while facilitating equity, diversity and inclusion in research through accessibility.

ASL Consent in the Digital Informed Consent Process
Ben S. Kosa, Ai Minakawa, Patrick Boudreault, Christian Vogler, Poorna Kushalnagar, Raja Kushalnagar
Journal on Technology & Persons with Disabilities, 2023
Abstract
There is an estimated 500,000 people in the U.S. who are deaf and who use ASL and live in the U.S. Compared to the general population, deaf people are at greater risk of having chronic health problems and experience significant health disparities and inequities (Sanfacon, Leffers, Miller, Stabbe, DeWindt, Wagner, & Kushalnagar, 2020; Kushalnagar, Reesman, Holcomb, & Ryan, 2019; Kushalnagar & Miller, 2019). Much of the disparities are explained by the barriers in the environment, such as the unavailability of materials in ASL and lack of healthcare professionals who know how to provide deaf patient-centered care. Intersecting social determinants of health (e.g., intrinsic – low education; and extrinsic – barrier to healthcare services) create a mutually constituted vulnerability for healthdisparities when a person is deaf (Kushalnagar & Miller, 2019; Lesch, Brucher, Chapple, R., & Chapple, K., 2019; Smith & Chin, 2012). Moreover, the longstanding history of inequitable access to language and education, and a lack of printed information and materials, leave people who are deaf and use ASL unaware of opportunities to participate in cutting-edge research/clinical trials. An unintended consequence, therefore, is that PIs neglect to include people who are deaf and use ASL in their subject sample pools, and this marginalized population continues to be at disparity for health outcomes and also clinical research participation. One barrier is the unavailability of informed consent materials that are accessible in ASL. The current research study conducted by our team at the Center for Deaf Health Equity at Gallaudet University attempts to address the language barrier to the consent process through a careful reconsideration of its traditional English format and the development of an American Sign Language (ASL) informed consent app. This team successfully leveraged existing machine learning methods to develop a way to navigate and signature an informed consent process using ASL. We call this new method of navigation and signature “ASL consent.” In our findings, we found that deaf people who are primarily college educated were more likely to agree that the process for obtaining ASL consent through an accessible app is comparable to traditional English consent.

Informed consent practices in clinical research: present and future

Informed consent practices in clinical research: present and future
Natasha A Jawa, J Gordon Boyd, David M Maslove, Stephen H Scott, Samuel A Silver
Postgraduate Medical Journal, 2 June 2023
Abstract
Clinical research must balance the need for ambitious recruitment with protecting participants’ autonomy; a requirement of which is informed consent. Despite efforts to improve the informed consent process, participants are seldom provided sufficient information regarding research, hindering their ability to make informed decisions. These issues are particularly pervasive among patients experiencing acute illness or neurological impairment, both of which may impede their capacity to provide consent. There is a critical need to understand the components, requirements, and methods of obtaining true informed consent to achieve the vast numbers required for meaningful research. This paper provides a comprehensive review of the tenets underlying informed consent in research, including the assessment of capacity to consent, considerations for patients unable to consent, when to seek consent from substitute decision-makers, and consent under special circumstances. Various methods for obtaining informed consent are addressed, along with strategies for balancing recruitment and consent.

Trusting relationships between patients with non-curative cancer and healthcare professionals create ethical obstacles for informed consent in clinical trials: a grounded theory study

Trusting relationships between patients with non-curative cancer and healthcare professionals create ethical obstacles for informed consent in clinical trials: a grounded theory study
Mary Murphy, Eilis McCaughan, Gareth Thompson, Matthew A. Carson, Jeffrey R Hanna, Monica Donovan, Richard Wilson, Donna Fitzsimons
BMC Palliative Care, 21 June 2023
Abstract
Background
Clinical trial participation for patients with non-curative cancer is unlikely to present personal clinical benefit, which raises the bar for informed consent. Previous work demonstrates that decisions by patients in this setting are made within a ‘trusting relationship’ with healthcare professionals. The current study aimed to further illuminate the nuances of this relationship from both the patients’ and healthcare professionals’ perspectives.
Methods
Face-to-face interviews using a grounded theory approach were conducted at a regional Cancer Centre in the United Kingdom. Interviews were performed with 34 participants (patients with non-curative cancer, number (n) = 16; healthcare professionals involved in the consent process, n = 18). Data analysis was performed after each interview using open, selective, and theoretical coding.
Results
The ‘Trusting relationship’ with healthcare professionals underpinned patient motivation to participate, with many patients ‘feeling lucky’ and articulating an unrealistic hope that a clinical trial could provide a cure. Patients adopted the attitude of ‘What the doctor thinks is best’ and placed significant trust in healthcare professionals, focusing on mainly positive aspects of the information provided. Healthcare professionals recognised that trial information was not received neutrally by patients, with some expressing concerns that patients would consent to ‘please’ them. This raises the question: Within the trusting relationship between patients and healthcare professionals, ‘Is it possible to provide balanced information?’. The theoretical model identified in this study is central to understanding how the trusting professional-patient relationship influences the decision-making process.
Conclusion
The significant trust placed on healthcare professionals by patients presented an obstacle to delivering balanced trial information, with patients sometimes participating to please the ‘experts’. In this high-stakes scenario, it may be pertinent to consider strategies, such as separation of the clinician-researcher roles and enabling patients to articulate their care priorities and preferences within the informed consent process. Further research is needed to expand on these ethical conundrums and ensure patient choice and autonomy in trial participation are prioritised, particularly when the patient’s life is limited.

Xenotransplantation and Informed Consent

Xenotransplantation and Informed Consent
Book Chapter
Daniel J. Hurst
Xenotransplantation, 22 June 2023 [Springer]
Abstract
Xenotransplantation (XTx; particularly, pig-to-human transplant) clinical trials of solid organs are likely on the horizon. There is a rich literature noting ethical issues that are particular to XTx clinical trials. Because of these ethical particularities and peculiarities, the informed consent process for XTx has been seen by some commentators as a very challenging endeavor. While organ transplant appears to be on the verge of a wave of XTx clinical trials, it can be surprising that more recent standardized guidance on proper informed consent for these trials is largely missing from the literature. This chapter provides an overview of where the major debates in XTx informed consent lay and attempts to provide some clarity for a way forward.

Who owns your consent? How REBs give away participants’ agency

Who owns your consent? How REBs give away participants’ agency
Janice Aurini, Vanessa Iafolla
Research Ethics, 14 June 2023
Abstract
We draw on three illustrative vignettes to examine how REBs manage participants’ agency in the context of qualitative research. We ask: Who owns a participant’s consent? Central to informed consent is the principle of Respect for Persons, which privileges the autonomy of individuals to make decisions about what happens (or not) to them. Yet, REBs sometimes require researchers to get permission from organizations to conduct research on their current and former members, even when the research is not about those organizations. Our aim is to raise awareness about the inherent contradictions of this practice and to consider guidelines for determining the appropriateness of involving organizations that may be tangentially connected to the research objectives or potential participants.

Editor’s note: REB in the abstract above refers to a research ethics board.

Reshaping consent so we might improve participant choice (II) – helping people decide

Reshaping consent so we might improve participant choice (II) – helping people decide
Research Article
Hugh Davies, Rosie Munday, Maeve O’Reilly, Catriona Gilmour Hamilton, Arzhang Ardahan, Simon E Kolstoe, Katie Gillies
Research Ethics, 12 June 2023
Open Access
Abstract
Research consent processes must provide potential participants with the necessary information to help them decide if they wish to join a study. On the Oxford ‘A’ Research Ethics Committee we’ve found that current research proposals mostly provide adequate detail (even if not in an easily comprehensible format), but often fail to support decision making, a view supported by published evidence. In a previous paper, we described how consent might be structured, and here we develop the concept of an Information and Decision Aid (IDA) that can support decision making and be used to guide the dialogue between researcher and potential participant. Our proposal requires limited changes to current processes or paperwork and would provide an easily accessible document for others that the potential participant might approach for advice. It could later be integrated with the Informed Consent Form to ensure all matters of concern to the individual participant have been addressed before consent is formally signed off.

Parental perceptions of informed consent in neonatal emergency research

Parental perceptions of informed consent in neonatal emergency research
Susanne Tippmann, Janine Schäfer, Christine Arnold, Julia Winter, Norbert Paul, Eva Mildenberger, André Kidszun
Z Geburtshilfe Neonatol, 2023; 227(03)
Abstract
Background and Objective
Obtaining informed consent in neonatal emergency research is challenging. The aim of this study was to assess parental perceptions of informed consent following participation in a clinical trial in neonatal emergency care.
Methods
This was a supplementary analysis of a randomised controlled trial comparing video and direct laryngoscopy for neonatal intubation. After obtaining informed consent for the clinical trial, parents were asked to answer a series of self-administered questions about their perceptions of the consent process. Informed consent had been given either before birth, after birth but before inclusion in the trial, or after inclusion in the trial.
Results
Of the 63 preterm and term infants who participated in the study, we received responses from 33 mothers and 27 fathers (n = 60). Fifty-four (91.5%, n = 59) parents agreed that infants should participate in clinical trials. Fifty-one (85%) parents agreed that parents should be asked for their consent to participate in research studies involving their children. A minority of six (10%) parents would prefer not to be asked to consent to their infant participating in the study. Fifty-three (89.8%, n = 59) parents felt that their infant’s participation in this particular trial would be beneficial. Twelve (20%) parents thought that infants who take part in clinical trials generally get better treatment. Almost all parents (56 (93.3%)) felt well informed about the purpose of the trial. Fifty-two (86.7%) parents felt that the informed consent process was satisfactory. One parent (100%, n=1) approached before birth, 23 parents (82.1%, n=28) approached after birth but before enrolment and 26 (83.9%, n=31) parents approached after enrolment were satisfied with the timing of the consent process. Eight (13.3%) parents felt pressured to agree to participate in the study. Of these, two (25%) were approached before enrolment and six (75%) were approached after enrolment. When asked about the best time to discuss consent with parents in clinical trials in neonatal emergency care, 20 (33%) parents said it was before birth, while 40 (67%) parents said it was after birth.
Conclusion
Parents valued their infant’s participation in a clinical trial in neonatal emergency care and considered it important to be asked for consent. Timing seemed to be less important. Deferred consent appears to be a feasible approach to obtaining informed consent for clinical trials in neonatal emergency care. However, future studies need to investigate whether parents feel more pressured to give consent in this way.

Parents’ perceptions of parental consent procedures for social science research in the school context

Parents’ perceptions of parental consent procedures for social science research in the school context
Thabo J van Woudenberg, Esther Rozendaal, Moniek Buijzen
International Journal of Social Research Methodology, 21 June 2023
Abstract
Typically, parents or other legal guardians are asked for an active declaration that the participation of their child in scientific research is informed and voluntary. However, asking for active parental consent leads to lower quality studies and passive parental consent might be preferable. In this study, we used an online survey in which parents (N = 156) watched video vignettes of multiple types of research in the classroom and asked them to rate the appropriateness of using active and passive parental consent. The results indicated that parents perceived active consent procedures as more appropriate in most types of research. However, particularly for secondary school children passive consent was rated as comparably appropriate for several types of research (e.g. observation and questionnaire studies). Other aspects of providing consent are displayed in a supplementary online dashboard. We conclude with recommendations for parental consent procedures for social science research in the school context.

Transplant Recipient Preferences Regarding Organ Donor Research: Their Role in Consent and use of Their Data

Transplant Recipient Preferences Regarding Organ Donor Research: Their Role in Consent and use of Their Data
Research Article
Amanda Lucas, Patricia H. Strachan, Frederick D’Aragon, Aimee J. Sarti, Maureen O. Meade
Journal of Empirical Research on Human Research Ethics, 12 June 2023
Abstract
Research on deceased organ donors has been hindered by concerns related to seeking research consent from transplant recipients. We undertook this qualitative study to elucidate solid organ transplant recipients views on organ donor research, their role in the consent for such research, and their preferences related to providing their data. We conducted interviews with 18 participants and three themes emerged from the data. The first centered around participant research literacy. The second described practical preferences of participating in research, and the third related to the connection between donor and recipient. We concluded that previously held views about the requirement for transplant recipients to have a consenting role in donor research is not always suitable.